Sofiya Latifyan

2.9k total citations · 1 hit paper
24 papers, 1.9k citations indexed

About

Sofiya Latifyan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Sofiya Latifyan has authored 24 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Sofiya Latifyan's work include Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (4 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Sofiya Latifyan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (4 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Sofiya Latifyan collaborates with scholars based in Switzerland, United States and Belgium. Sofiya Latifyan's co-authors include Olivier Michielin, Michel Obéid, Solange Peters, Montserrat Fraga, Thierry Küntzer, Faïza Lamine, John A. Thompson, Camillo Ribi, Gerasimos P. Sykiotis and Keyvan Shabafrouz and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Nature Reviews Clinical Oncology.

In The Last Decade

Sofiya Latifyan

23 papers receiving 1.8k citations

Hit Papers

Adverse effects of immune-checkpoint inhibitors: epidemio... 2019 2026 2021 2023 2019 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
    2019 1.5k citations Filipe Martins, Sofiya Latifyan et al. Nature Reviews Clinical Oncology profile →

Peers

Sofiya Latifyan
Filipe Martins Switzerland
Anne Cairoli Switzerland
Keyvan Shabafrouz Switzerland
Matthieu Texier France
C. Boutros France
Louise C. Connell United States
Ulf Petrausch Switzerland
Antonio Maria Grimaldi Italy
Parisa Momtaz United States
Katja Schindler United States
Filipe Martins Switzerland
Sofiya Latifyan
Citations per year, relative to Sofiya Latifyan Sofiya Latifyan (= 1×) peers Filipe Martins

Countries citing papers authored by Sofiya Latifyan

Since Specialization
Citations

This map shows the geographic impact of Sofiya Latifyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofiya Latifyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofiya Latifyan more than expected).

Fields of papers citing papers by Sofiya Latifyan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofiya Latifyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofiya Latifyan. The network helps show where Sofiya Latifyan may publish in the future.

Co-authorship network of co-authors of Sofiya Latifyan

This figure shows the co-authorship network connecting the top 25 collaborators of Sofiya Latifyan. A scholar is included among the top collaborators of Sofiya Latifyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofiya Latifyan. Sofiya Latifyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Latifyan, Sofiya & John B.A.G. Haanen. (2024). Melanoma neoantigen vaccines: Are we getting more personal now?. Med. 5(4). 288–290. 1 indexed citations
2.
Obéid, Michel, Victor Joo, Douglas Daoudlarian, et al.. (2024). High-dimensional longitudinal immune profiling uncovers a dual role of the CXCL9/CXCR3, CXCL13/CXCR5, and CCL11/CCL3 axis in the coupling of immune-related adverse events to immune checkpoint inhibitor response.. Journal of Clinical Oncology. 42(16_suppl). 2512–2512. 1 indexed citations
3.
Joo, Victor, Alessandra Noto, Sofiya Latifyan, et al.. (2024). Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma. Nature Communications. 15(1). 3664–3664. 5 indexed citations
4.
Courlet, Perrine, Daniel Abler, Monia Guidi, et al.. (2023). Modeling tumor size dynamics based on real‐world electronic health records and image data in advanced melanoma patients receiving immunotherapy. CPT Pharmacometrics & Systems Pharmacology. 12(8). 1170–1181. 7 indexed citations
5.
6.
7.
Wicky, Alexandre, Roberto Gatta, Sofiya Latifyan, et al.. (2023). Interactive process mining of cancer treatment sequences with melanoma real-world data. Frontiers in Oncology. 13. 1043683–1043683. 1 indexed citations
8.
Hottinger, Andreas F., Sofiya Latifyan, Sarah Boughdad, et al.. (2023). Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series. Journal of Neurology. 271(4). 1947–1958. 9 indexed citations
9.
Abler, Daniel, Perrine Courlet, Roberto Gatta, et al.. (2023). Semiautomated Pipeline to Quantify Tumor Evolution From Real-World Positron Emission Tomography/Computed Tomography Imaging. JCO Clinical Cancer Informatics. 7(7). e2200126–e2200126. 2 indexed citations
10.
Latifyan, Sofiya, et al.. (2022). 2022-RA-1349-ESGO Treated as a skin carcinoma: recurrent, metastatic squamous cell carcinoma from a degenerated mature teratoma of the ovary. International Journal of Gynecological Cancer. 32. A327–A328.
11.
Koch, Lukas, Joanna Mangana, Sofiya Latifyan, et al.. (2021). Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany. Journal for ImmunoTherapy of Cancer. 9(2). e001701–e001701. 38 indexed citations
12.
Boughdad, Sarah, Sofiya Latifyan, Craig Fenwick, et al.. (2021). 68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis. Journal for ImmunoTherapy of Cancer. 9(10). e003594–e003594. 49 indexed citations
13.
Pasche, Philippe, et al.. (2021). Mucosal Melanoma of the Head and Neck: A Retrospective Review and Current Opinion. Frontiers in Surgery. 7. 616174–616174. 6 indexed citations
14.
Fernandez, Pierre-Alain, Maja Beck‐Popovic, Manuel Diezi, et al.. (2021). Cancer Care of Children, Adolescents and Adults With Autism Spectrum Disorders: Key Information and Strategies for Oncology Teams. Frontiers in Oncology. 10. 595734–595734. 3 indexed citations
15.
Martins, Filipe, Sofiya Latifyan, Gerasimos P. Sykiotis, et al.. (2019). Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. Nature Reviews Clinical Oncology. 16(9). 563–580. 1544 indexed citations breakdown →
16.
17.
Solinas, Cinzia, Andrea Gombos, Sofiya Latifyan, et al.. (2017). Targeting immune checkpoints in breast cancer: an update of early results. ESMO Open. 2(5). e000255–e000255. 119 indexed citations
18.
Sideris, Spyridon, Fouad Aoun, Sofiya Latifyan, et al.. (2016). Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients. Journal of Endocrinological Investigation. 39(7). 729–738. 6 indexed citations
19.
Latifyan, Sofiya, et al.. (2016). Bisphosphonate-related osteonecrosis of the jaw: a review of the potential efficacy of low-level laser therapy. Supportive Care in Cancer. 24(9). 3687–3693. 20 indexed citations
20.
Latifyan, Sofiya, et al.. (2014). Tumour-associated osteomalacia and hypoglycaemia in a patient with prostate cancer: is Klotho involved?. BMJ Case Reports. 2014. bcr2014206590–bcr2014206590. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Filipe Martins Breakdown of academic impact, for papers by Anne Cairoli Breakdown of academic impact, for papers by Keyvan Shabafrouz Breakdown of academic impact, for papers by Matthieu Texier Breakdown of academic impact, for papers by C. Boutros Breakdown of academic impact, for papers by Louise C. Connell Breakdown of academic impact, for papers by Ulf Petrausch Breakdown of academic impact, for papers by Antonio Maria Grimaldi Breakdown of academic impact, for papers by Parisa Momtaz Breakdown of academic impact, for papers by Katja Schindler
Rankless by CCL
2026